Skip to main content

DNA Link Buys Orchid SNPStream System

NEW YORK, June 4 - DNA Link of Seoul, South Korea, has agreed to buy Orchid’s SNPstream 25K SNP-scoring system, the companies said.

"We acquired Orchid’s SNPstream 25K automated genotyping solution to enable us to accelerate our varied programs in medical genetics," Jong Eun Lee, co-CEO of DNA Link, said recently in a statement.

“We expect that the SNPstream system’s mix of accuracy, robustness, and cost effectiveness combined with access to Orchid’s growing SNP databases will contribute to the rapid progress of our gene discovery and pharmacogenetics programs,” he said.

DNA Link, a medical genetics research company, is Orchid’s first customer in Asia to buy the SNPstream system, which can analyze up to 25,000 SNPs per day.  

Financial terms of the agreement were not disclosed.

In addition to the SNPstream system, Orchid BioSciences of Princeton, NJ, also offers SNP scoring and pharmacogenetic testing services.

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.